Senti Biosciences is trading 5.88% up now at $0.38, with broader sentiment supportive but no verified company-specific announcement identified for August 7, 2026.
- The latest notable transaction was announced July 15 and involved a strategic restructuring and potential $60 million in milestone payments tied to SENTI-202.
- The Nasdaq Composite was up 0.95% pre-market; confidence remains limited because no direct catalyst was found.